Stock
Purchase Agreement


 


 


Dated as of December 17, 2012


 


 


By and Among


 


 


IRINA CUDINA,


 


 


ALEX STANBURY,


 


and


 


FARMACIA CORPORATION


 


 


 






    	 



    	 	



    



 





Stock
Purchase Agreement


 


This stock purchase
agreement (“Agreement”), dated as of December __, 2012, is entered into by and among FARMACIA CORPORATION (“Farmacia”
or the “Company”) and IRINA CUDINA (the “Seller”), and ALEX STANBURY (the “Purchaser”
and together with the Company and the Seller, the “Parties”).


 


W
i t n e s s e t h:


 


Whereas,
the Seller is a shareholder of Farmacia, a corporation organized and existing under the laws of the State of Nevada, who owns and/or
controls in the aggregate 1,100,000 shares of common stock, par value $0.00001 per share, of the Company, which represents 52%
of the issued and outstanding shares; and


 


Whereas,
the Purchaser desires to acquire 1,100,000 shares.


 


Now,
Therefore, in consideration of the premises and of the covenants, representations, warranties and agreements herein
contained, the Parties have reached the following agreement with respect to the sale by the Seller of such shares to the Purchaser:


 


Section
1. Construction and Interpretation


 


1.1. Principles of
Construction.


 


(a) All references
to Articles, Sections, subsections and Appendixes are to Articles, Sections, subsections and Appendixes in or to this Agreement
unless otherwise specified. The words “hereof,” “herein” and “hereunder” and words of similar
import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.
The term “including” is not limiting and means “including without limitations.”


 


(b) In the computation
of periods of time from a specified date to a later specified date, the word “from” means “from and including;”
the words “to” and “until” each mean “to but excluding;” and the word “through”
means “to and including.”


 


(c) This Agreement
is the result of negotiations among and has been reviewed by each Party’s counsel. Accordingly, this Agreement shall not
be construed against any Party merely because of such Party’s involvement in its preparation.


 


(d) Wherever in this
Agreement the intent so requires, reference to the neuter, masculine or feminine shall be deemed to include each of the other,
and reference to either the singular or the plural shall be deemed to include the other.


 


Section
2. The Transaction


 


2.1. Purchase Price.


 


The Seller hereby agrees
to sell to the Purchaser, and the Purchaser, in reliance on the representations and warranties contained herein, and subject to
the terms and conditions of this Agreement, agrees to purchase from the Seller 1,100,000 shares (the “Acquired Shares”)
for a total purchase price of $40,000 (the “Purchase Price”), payable in full to the Seller according to the
terms of this Agreement, in United States currency as directed by the Seller at the closing of the transaction contemplated herein
(the “Closing”).


 






    	 



    	 	



    



 


2.2. Transfer of Shares
and Terms of Payment.


 


In consideration for
the transfer of the Acquired Shares by the Seller to the Purchaser, the Purchaser shall pay the Purchase Price in accordance with
the terms of this Agreement. Transfer of the shares and payment thereof shall be in the following manner:


 


		i)	Upon execution of this Agreement, the Purchaser shall transfer the Purchase Price to Anslow &
Jaclin, LLP (the “Escrow Agent”);



 


		ii)	Simultaneously with the transfer of the Purchase Price, the Seller shall deliver to the Escrow
Agent the certificates for the Acquired Shares duly endorsed for transfer or with executed stock powers medallion guaranteed attached
to be released and delivered to Purchaser upon receipt of the Purchase Price by the Escrow Agent.



 


2.3. Closing.


 


Subject to the terms
and conditions of this Agreement, the Closing shall take place by wire transfer and overnight mail on or before December __, 2012
(the “Closing Date”).


 


Section
3. Representations and Warranties 


 


3.1. Representations
and Warranties of the Seller and the Company. The Seller and the Company hereby make the following representations and warranties
to the Purchaser:


 


3.1.1The Company
is a corporation duly organized and validly existing under the laws of the State of Nevada and has all corporate power necessary
to engage in all transactions in which it has been involved, as well as any general business transactions in the future that may
be desired by its directors.


 


3.1.2The Company
is in good standing with the Secretary of State of Nevada.


 


3.1.3Prior to or at Closing, all
of the Company’s outstanding debts and obligations shall be paid off (at no expense or liability to the Purchaser) and the
Seller shall provide evidence of such payoff to the Purchaser’s reasonable satisfaction. Should the Purchaser discover any
obligation of the Company that was not paid prior to the Closing Date, the Seller shall indemnify the Purchaser for any and all
such liabilities, whether outstanding or contingent at the time of Closing.


 


3.1.4The Company
will have no assets or liabilities at the Closing Date.


 


3.1.5The Company
is not subject to any pending or threatened litigation, claims or lawsuits from any party, and there are no pending or threatened
proceedings against the Company by any federal, state or local government, or any department, board, agency or other body thereof.


 


3.1.6The Company
is not a party to any contract, lease or agreement which would subject it to any performance or business obligations after the
Closing.


 






    	2



    	 



    



 


3.1.7The Company
does not own any real estate or any interests in real estate.


 


3.1.8The Company
is not liable for any taxes, including income, real or personal property taxes, to any governmental or state agencies whatsoever.
The Company has timely filed all income, real or personal property, sales, use, employment or other governmental tax returns or
reports required to be filed by it with any federal, state or other governmental agency and all taxes required to be paid by the
Company in respect of such returns have been paid in full. None of such returns are subject to examination by any such taxing authority
and the Company has not received notice of any intention to require the Company to file any additional tax returns in any jurisdiction
to which it may be subject.


 


3.1.9The Company,
to the actual knowledge of Seller, is not in violation of any provision of laws or regulations of federal, state or local government
authorities and agencies.


 


3.1.10The Seller
is the lawful owner of record of the Acquired Shares, and the Seller presently has, and will have at the Closing Date, the power
to transfer and deliver the Acquired Shares to the Purchaser in accordance with the terms of this Agreement. The delivery to the
Purchaser of certificates evidencing the transfer of the Acquired Shares pursuant to the provisions of this Agreement will transfer
to the Purchaser good and marketable title thereto, free and clear of all liens, encumbrances, restrictions and claims of any kind.


 


3.1.11There are
no authorized shares of the Company other than 75,000,000 common shares, and there are 2,100,000 issued and outstanding shares
of the Company. Seller at the Closing Date will have full and valid title to the Acquired Shares, and there will be no existing
impediment or encumbrance to the sale and transfer of the Acquired Shares to the Purchaser; and on delivery to the Purchaser of
the Acquired Shares being sold hereby, all of such Shares shall be free and clear of all liens, encumbrances, charges or assessments
of any kind; such Shares will be legally and validly issued and fully paid and non-assessable shares of the Company’s common
stock; and all such common stock has been issued under duly authorized resolutions of the Board of Directors of the Company.


 


3.1.12All issuances
of the Company of the Shares in past transactions have been legally and validly effected, without violation of any preemptive rights,
if any existed, and all of such shares of common stock are fully paid and non-assessable.


 


3.1.13There are no outstanding subscriptions, options,
warrants, convertible securities or rights or commitments of any nature in regard to the Company’s authorized but unissued
common stock or any agreements restricting the transfer of outstanding or authorized but unissued common stock. There are no shareholders
agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among any of the Company’s shareholders.


 


3.1.14There are
no outstanding judgments, liens or any other security interests filed against the Company or any of its properties.


 


3.1.15The Company
has no subsidiaries.


 






    	3



    	 



    



 


3.1.16The Company
has no employment contracts or agreements with any of its officers, directors, or with any consultants; and the Company has no
employees or other such parties.


 


3.1.17The Company
has no insurance or employee benefit plans whatsoever.


 


3.1.18The Company
is not in default under any contract, or any other document.


 


3.1.19The Company
has no outstanding powers of attorney and no obligations concerning the performance of the Seller concerning this Agreement.


 


3.1.20The execution
and delivery of this Agreement, and the subsequent Closing, will not result in the breach by the Company or the Seller of (i) any
agreement or other instrument to which they are or have been a party or (ii) the Company’s Articles of Incorporation or Bylaws.


 


3.1.21All financial
and other information which the Company and/or the Seller furnished or will furnish to the Purchaser, including information with
regard to the Company and/or the Seller contained in the SEC filings filed by the Company since its inception (i) is true, accurate
and complete as of its date and in all material respects except to the extent such information is superseded by information marked
as such, (ii) does not omit any material fact and is not misleading, and (iii) presents fairly the financial condition of the organization
as of the date and for the period covered thereby.


 


3.1.22The Company
has a Registration Statement on Form S-1 that went effective on May 19, 2011, and there are no proceedings pending to revoke or
terminate such registration. Since such date, the Company has filed all periodic reports with the Securities and Exchange Commission
pursuant to the Securities Exchange Act of 1934, as amended, including its Quarterly Report on Form 10-Q for the period ended July
31, 2012, and all such reports were filed timely.


 


The representations
and warranties herein by the Seller and the Company shall be true and correct in all material respects on and as of the Closing
Date hereof with the same force and effect as though said representations and warranties had been made on and as of the Closing
Date.


 


The representations
and warranties made above shall survive the Closing Date and shall expire for all purposes in the date numerically corresponding
to the Closing Date in the thirty sixth month after the Closing Date.


 


3.2. Covenants of the
Seller and the Company.


 


From the date of this
Agreement and until the Closing Date, the Seller and the Company covenant the following:


 


3.2.1The Seller
will, to the best of her ability, preserve intact the effectiveness of the Company’s Registration Statement on Form S-1.


 


3.2.2The Seller
will furnish Purchaser with all corporate records and documents, such as Articles of Incorporation and Bylaws, minute books, stock
books, or any other corporate document or record (including financial and bank documents, books and records) requested by the Purchaser.


 






    	4



    	 



    



 


3.2.3The Company
will not enter into any contract or business transaction, merger or business combination, make any material purchases or acquisitions,
or incur any further debts or obligations without the express written consent of the Purchaser.


 


3.2.4The Company
will not amend or change its Articles of Incorporation or Bylaws, or issue any further shares or create any other class of shares
in the Company without the express written consent of the Purchaser.


 


3.2.5The Company
will not issue any stock options, warrants or other rights or interests in or to its shares without the express written consent
of the Purchaser.


 


3.2.6The Seller
will not encumber or mortgage any right or interest in her Shares being sold to the Purchaser hereunder, and also they will not
transfer any rights to such shares of the common stock to any third party whatsoever.


 


3.2.7The Company
will not declare any dividend in cash or stock, or any other benefit.


 


3.2.8The Company
will not institute any bonus, benefit, profit sharing, stock option, pension retirement plan or similar arrangement.


 


3.2.9At Closing,
the Company and the Seller will obtain and submit to the Purchaser resignations of current officers and directors.


 


3.2.10The Seller
agrees to indemnify the Purchaser against and to pay any loss, damage, expense or claim or other liability incurred or suffered
by the Purchaser by reason of the breach of any covenant or inaccuracy of any warranty or representation contained in this Agreement.


 


3.2.11 For thirty-six
months after Closing, the Seller agrees to cooperate with the Purchaser and provide the Purchaser and the Company with any documentation
and assistance that they may reasonable require to file Exchange Act on behalf of the Company.


 


3.3Representations
and Warranties of the Purchaser. The Purchaser hereby makes the following representations and warranties to the Seller:


 


3.3.1The
Purchaser has the requisite power and authority to enter into and perform this Agreement and to purchase the shares being sold
to it hereunder. The execution, delivery and performance of this Agreement by such Purchaser and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action, and no further consent or authorization
of such Purchaser is required. This Agreement has been duly authorized, executed and delivered by such Purchaser and constitutes,
or shall constitute when executed and delivered, a valid and binding obligation of such Purchaser enforceable against such Purchaser
in accordance with the terms thereof.


 






    	5



    	 



    



 


3.3.2The Purchaser
is, and will be at the time of the execution of this Agreement, an “accredited investor”, as such term is defined
in Regulation D promulgated by the Commission under the Securities Act of 1933, as amended (the “1933 Act”), is experienced
in investments and business matters, has made investments of a speculative nature and has purchased securities of United States
publicly-owned companies in the past and, with its representatives, has such knowledge and experience in financial, tax and other
business matters as to enable such Purchaser to utilize the information made available by the
Company to evaluate the merits and risks of and to make an informed investment decision with respect to the proposed purchase,
which represents a speculative investment. The Purchaser has the authority and is duly and legally qualified to purchase and own
shares of the Company. The Purchaser is able to bear the risk of such investment for an indefinite period and to afford a complete
loss thereof. The information set forth on the signature page hereto regarding the
Purchaser is accurate.


 


3.3.3On the Closing
Date, such Purchaser will
purchase the Acquired Shares pursuant to the terms of this Agreement for its own account for investment only and not with a view
toward, or for resale in connection with, the public sale or any distribution thereof.


 


3.3.4The Purchaser
understands and agrees that the Acquired Shares have not been registered under the 1933 Act or any applicable state securities
laws, by reason of their issuance in a transaction that does not require registration under the 1933 Act (based in part on the
accuracy of the representations and warranties of the Purchaser
contained herein), and that such Acquired Shares must be held indefinitely unless a subsequent disposition is registered
under the 1933 Act or any applicable state securities laws or is exempt from such registration. In any event, and subject to compliance
with applicable securities laws, the Purchaser may enter into lawful hedging transactions in the course of hedging the position
they assume and the Purchaser may also enter into lawful short positions or other derivative transactions relating to the Acquired
Shares, or interests in the Acquired Shares, and deliver the Acquired Shares, or interests in the Acquired Shares, to close out
their short or other positions or otherwise settle other transactions, or loan or pledge the Acquired Shares, or interests in
the Acquired Shares, to third parties who in turn may dispose of these Acquired Shares.


 


3.3.5The
Acquired Shares shall bear the following or similar legend:


 


“THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, NOR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN
THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B)
AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”


 






    	6



    	 



    



 


3.3.6The offer
to sell the Acquired Shares was directly communicated to the Purchaser by the Company. At no time was the Purchaser presented with
or solicited by any leaflet, newspaper or magazine article, radio or television advertisement, or any other form of general advertising
or solicited or invited to attend a promotional meeting otherwise than in connection and concurrently with such communicated offer.


 


3.3.7Such Purchaser
represents that the foregoing representations and warranties are true and correct as of the date hereof and, unless such Purchaser
otherwise notifies the Company prior to the Closing Date shall be true and correct as of the Closing Date.


 


3.3.8The foregoing
representations and warranties shall survive the Closing Date and for a period of one year thereafter.


 


Section
4. Miscellaneous 


 


4.1. Expenses.


 


Each of the Parties
shall bear his own expenses in connection with the transactions contemplated by this Agreement.


 


4.2. Governing Law.


 


The interpretation
and construction of this Agreement, and all matters relating hereto, shall be governed by the laws of the State of Nevada applicable
to agreements executed and to be wholly performed solely within such state.


 


4.3. Resignation of
Old and Appointment of New Board of Directors and Officers.


 


The Company and the
Seller shall take such corporate action(s) required by the Company’s Articles of Incorporation and/or Bylaws to (a) appoint
the below named persons to their respective positions, to be effective on the eleventh day following the Closing Date, and (b)
obtain and submit to the Purchaser, together with all required corporate action(s) the resignation of the current board of directors,
and any and all corporate officers and check signers as of the Closing Date.


 


	Name	Position
	Alex Stanbury	Director, President, CFO and CEO


 


4.4. Disclosure.


 


The Seller and the
Company agree that they will not make any public comments, statements, or communications with respect to, or otherwise disclose
the execution of this Agreement or the terms and conditions of the transactions contemplated by this Agreement without the prior
written consent of the Purchaser, which consent shall not be unreasonably withheld.


 






    	7



    	 



    



 


4.5. Notices.


 


Any notice or other
communication required or permitted under this Agreement shall be sufficiently given if delivered in person or sent by facsimile
or by overnight registered mail, postage prepaid, addressed as follows:


 


If to Seller, to:


 


Irina Cudina


 


If to the Company:


 


Farmacia Corporation


c/o Anslow & Jaclin, LLP

195 Route 9, Suite 204


Manalapan, NJ 07726


 


With a copy to (which
shall not constitute notice):


 


Anslow & Jaclin,
LLP


195 Route 9, Suite
204


Manalapan, NJ 07726


 


If to the Purchaser, to:


 


Alex Stanbury


____________________


____________________


 


Or such other address
or number as shall be furnished in writing by any such Party, and such notice or communication shall, if properly addressed, be
deemed to have been given as of the date so delivered or sent by facsimile.


 


4.6. Parties in Interest.


 


This Agreement may
not be transferred, assigned or pledged by any Party hereto, other than by operation of law. This Agreement shall be binding upon
and shall inure to the benefit of the Parties hereto and their respective heirs, executors, administrators, successors and permitted
assigns.


 


4.7. Entire Agreement.


 


This Agreement and
the other documents referred to herein contain the entire understanding of the Parties hereto with respect to the subject matter
contained herein. This Agreement shall supersede all prior agreements and understandings between the Parties with respect to the
transactions contemplated herein.


 


4.8. Amendments.


 


This Agreement may
not be amended or modified orally, but only by an agreement in writing signed by the Parties.


 






    	8



    	 



    



 


4.9. Severability.


 


In case any provision
in this Agreement shall be held invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions
hereof will not in any way be affected or impaired thereby.


 


4.10. Counterparts.


 


This Agreement may
be executed in any number of counterparts, including counterparts transmitted by telecopier, PDF or facsimile transmission, any
one of which shall constitute an original of this Agreement. When counterparts of copies have been executed by all parties, they
shall have the same effect as if the signatures to each counterpart or copy were upon the same document and copies of such documents
shall be deemed valid as originals. The Parties agree that all such signatures may be transferred to a single document upon the
request of any Party.


 


[-signature
page follows-]


 


 



    	9



    	 



    



  


In
Witness Whereof, each of the Parties hereto has caused its/his
name to be hereunto subscribed as of the day and year first above written. 





 


		Company:	 
	 	 	 
	 	FARMACIA CORPORATION	 
	 	 	 
	 	 	 
	 	By: 	/s/ Irina Cudina              	 
	 	Name:	Irina Cudina	 
	 	Title: Chief Executive Officer	 
	 	 	 
	 	 	 
	 	Seller:	 
	 	 	 
	 	By: 	/s/ Irina Cudina	 
	 	Name: Irina Cudina, Individually	 
	 	 	 
	 	 	 
	 	Purchaser:	 
	 	 	 
	 	 	 
	 	By:	/s/ Alex Stanbury	 
	 	Name: Alex Stanbury 	 


 











    	10